Mercado Global de Análise Mutacional – Tendências do Setor e Previsão para 2028

Análise de mercado e insights do mercado de análise mutacional

A Data Bridge Market Research analisa que o mercado de análise mutacional apresentará um CAGR de cerca de 12,10% para o período de previsão de 2021-2028. O crescimento global do apoio à genómica em medicamentos avançados, o maior foco nas competências de investigação e desenvolvimento no que diz respeito a dispositivos médicos e na adopção de tecnologias avançadas de saúde e o aumento das despesas no desenvolvimento de infra-estruturas de saúde, especialmente nas economias em desenvolvimento, são os principais factores atribuíveis ao crescimento do mercado de análise mutacional.

A análise mutacional é um ramo da análise genómica em que a sequência do ADN é alterada devido a alguns fatores internos e externos. A análise mutacional é um desenvolvimento de ensaio fiável que é utilizado como deteção de mutações na sequenciação de nova geração.

O aumento da prevalência de programas de sequenciação genética de recém-nascidos em todo o mundo são os principais fatores que promovem o crescimento do mercado. O crescente foco nos avanços tecnológicos em saúde nos ensaios clínicos de sequenciação de nova geração (NSG), juntamente com o crescimento da indústria genómica, é outro determinante do crescimento do mercado. O aumento das proficiências em investigação e desenvolvimento, o aumento dos avanços nas técnicas não invasivas de rastreio do cancro e o aumento do apoio governamental à indústria genómica irão gerar ainda mais oportunidades lucrativas de crescimento do mercado.

No entanto, os elevados custos associados aos equipamentos irão inviabilizar a taxa de crescimento do mercado. A escassez de profissionais qualificados e de conhecimentos médicos representará ainda mais desafios para o mercado. Além disso, a falta de consciência nas economias atrasadas e subdesenvolvidas também prejudicará a taxa de crescimento do mercado.

This mutational analysis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on mutational analysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Mutational Analysis Market Scope and Market Size

The mutational analysis market is segmented on the basis of type, product, technique and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• The global mutational analysis market is segmented on the basis of type into missense mutation, nonsense mutation, insertion, deletion, duplication, frame shift mutation and repeat expansion.
• On the basis of product, the mutational analysis market is segmented into enzyme and substrate.
• On the basis of technique, the mutational analysis market is segmented into denaturing gradient gel electrophoresis (DGGE), constant denaturing gel electrophoresis (CDGE), temporal temperature gradient gel electrophoresis (TTGE), single- strand conformation polymorphism (SSCP), protein truncation test (PTT) and high resolution melt.   
• On the basis of end user, the mutational analysis market is segmented into academic research institutes, contract research organization and others.

Mutational Analysis Market Country Level Analysis

The mutational analysis market is analysed and market size insights and trends are provided by country, type, product, technique and end user as referenced above.

The countries covered in the mutational analysis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the mutational analysis market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the prevailing advanced healthcare technologies, supportive government policies for research and development proficiencies and growing prevalence of major players. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the growing genomics industry.

The country section of the mutational analysis market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare infrastructure growth installed base and new technology penetration

The mutational analysis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for mutational analysis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the mutational analysis market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Mutational Analysis Market Share Analysis

The mutational analysis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to mutational analysis market.

Os principais players abordados no relatório de mercado de análise mutacional são a Novartis AG, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Agilent Technologies Inc, GENERAL ELECTRIC COMPANY , PerkinElmer, Inc., QIAGEN, Eurofins Scientific, Quest Diagnostics Incorporated., Novogene Corporation., Promega Corporation., Luminex Corporation, Takara Bio Inc., Danaher., BioIVT., Elevate Scientific., Oxford Gene Technology IP Limited e Pacific Biosciences of California, Inc. entre outros players nacionais e globais. Os dados de quota de mercado estão disponíveis para a Global, América do Norte, Europa, Ásia-Pacífico (APAC), Médio Oriente e África (MEA) e América do Sul em separado. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

SKU-46697